IT CAN BE hard to know what to do when you’re dealing with hair loss. While dermatologists are specially trained to treat ...

A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes ...

Hims & Hers (HIMS) stock in focus as a U.S. court denies injunction to continue making cheap versions of Novo Nordisk's (NVO) ...

The regulator has given larger so-called outsourcing facilities, which make compounded drugs in bulk and are regulated by the agency, until May 22. Smaller compounding pharmacies, which make drugs to ...

Utkal Hospital has become the first healthcare provider in East India to adopt Salesforce Agentforce. Through the implementation of Agentforce and Salesforce Health Cloud, this strategic collaboration ...

A quick spray of medication might seem like an easy way to get thicker hair, but some people say one sold online has left ...

The Food and Drug Administration on Tuesday posted a warning about generic forms of a popular hair-loss medication often sold by major telehealth companies including Hims, Keeps and Ro, citing reports ...

A US judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes and ...

DBS Bank downgraded Novo Nordisk (NVO) to Sell from Buy with a DKK 330 price target Stay Ahead of the Market: Discover outperforming stocks ...